- Home
- CANF vs ZEO Comparison
CANF vs ZEO Comparison
Compare CANF & ZEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CANF
- ZEO
- Stock Information
- Founded
- CANF 1994
- ZEO 2005
- Country
- CANF Israel
- ZEO United States
- Employees
- CANF N/A
- ZEO N/A
- Industry
- CANF Biotechnology: Pharmaceutical Preparations
- ZEO
- Sector
- CANF Health Care
- ZEO
- Exchange
- CANF Nasdaq
- ZEO NYSE
- Market Cap
- CANF 14.4M
- ZEO 25.7M
- IPO Year
- CANF N/A
- ZEO N/A
- Fundamental
- Price
- CANF $1.48
- ZEO $2.04
- Analyst Decision
- CANF Strong Buy
- ZEO
- Analyst Count
- CANF 2
- ZEO 0
- Target Price
- CANF $14.00
- ZEO N/A
- AVG Volume (30 Days)
- CANF 1.2M
- ZEO 2.7M
- Earning Date
- CANF 12-31-2024
- ZEO 12-31-2024
- Dividend Yield
- CANF N/A
- ZEO N/A
- EPS Growth
- CANF N/A
- ZEO N/A
- EPS
- CANF N/A
- ZEO 0.67
- Revenue
- CANF $667,000.00
- ZEO $95,455,763.00
- Revenue This Year
- CANF $409.56
- ZEO N/A
- Revenue Next Year
- CANF N/A
- ZEO N/A
- P/E Ratio
- CANF N/A
- ZEO $3.06
- Revenue Growth
- CANF N/A
- ZEO N/A
- 52 Week Low
- CANF $1.29
- ZEO $1.05
- 52 Week High
- CANF $4.69
- ZEO $11.60
- Technical
- Relative Strength Index (RSI)
- CANF 35.58
- ZEO 54.35
- Support Level
- CANF $1.30
- ZEO $1.50
- Resistance Level
- CANF $1.72
- ZEO $3.05
- Average True Range (ATR)
- CANF 0.18
- ZEO 0.51
- MACD
- CANF -0.01
- ZEO -0.03
- Stochastic Oscillator
- CANF 17.92
- ZEO 43.26
About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can Fite Biofarma Ltd is an clinical-stage biopharmaceutical company. The company develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases. The company's platform technology utilizes the Gi protein associated A3 adenosine receptor, or A3AR, as a therapeutic target. The company's drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the common form of liver cancer, and a Phase IIb trial for the treatment of non-alcoholic steatohepatitis (NASH).
About ZEO ZEO ENERGY CORP
Zeo Energy Corp is a vertically integrated provider of residential solar energy systems, other energy efficient equipment and related services currently serving customers in Florida, Texas, Arkansas, and Missouri. Its primary business activity is selling and installing residential solar energy systems that homeowners use to supplement the amount of usable electricity required to power their homes.